BioProject

The current sudy aimed to evaluate the contribution of germline CNVs to hereditary breast cancer risk in Tunisian patients who were negative for pathogenic mutations in known breast cancer susceptibility genes. More...

The current sudy aimed to evaluate the contribution of germline CNVs to hereditary breast cancer risk in Tunisian patients who were negative for pathogenic mutations in known breast cancer susceptibility genes. Our findings revealed new insights regarding CNVs and breast cancer risk in the Tunisian population and suggest that both rare and common CNVs may contribute to disease susceptibility. Less...